Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Allylestrenol

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,857Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Organon Appoints Joseph Morrissey as Interim CEO
    Organon Appoints Joseph Morrissey as Interim CEO

    27 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251027288395/en/Organon-Appoints-Company-Executive-Joseph-Morrissey-as-Interim-CEO-and-Board-Chair-Carrie-Cox-as-Executive-Chair-Announces-Results-of-Audit-Committee-Investigation

    BUSINESSWIRE
    27 Oct 2025
    Share Share
    EC Approves Henlius, Organon's BILDYOS & BILPREVDA Biosimilars
    EC Approves Henlius, Organon's BILDYOS & BILPREVDA Biosimilars

    19 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-19/european-commission-ec-approves-henlius-and-organon-s-bildyos-denosumab-and-bilprevda-denosum

    PHARMAWEB
    19 Sep 2025
    Share Share
    FDA Approves Henlius and Organon's Bildyos and Bilprevda
    FDA Approves Henlius and Organon's Bildyos and Bilprevda

    02 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-02/us-food-and-drug-administration-fda-approves-henlius-and-organon-s-bildyos-denosumab-nxxp-and-b

    PHARMAWEB
    02 Sep 2025
    Share Share
    Organon Announces Q2 Results Ending June 30, 2025
    Organon Announces Q2 Results Ending June 30, 2025

    05 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250805011781/en/Organon-Reports-Results-for-the-Second-Quarter-Ended-June-30-2025

    BUSINESSWIRE
    05 Aug 2025
    Share Share
    Organon To Report Q2 2025 Results and Host Conference Call
    Organon To Report Q2 2025 Results and Host Conference Call

    22 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250722000126/en/Organon-To-Report-Second-Quarter-2025-Results-and-Host-Conference-Call-on-August-5-2025

    BUSINESSWIRE
    22 Jul 2025
    Share Share
    VTAMA® Cream Earns Top Spot in 2025 Derm Guidelines
    VTAMA® Cream Earns Top Spot in 2025 Derm Guidelines

    07 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250707974353/en/Organons-VTAMA-tapinarof-cream-1-Granted-Strong-Recommendation-in-the-American-Academy-of-Dermatology-Updated-2025-Guidelines-for-Adult-Atopic-Dermatitis

    BUSINESSWIRE
    07 Jul 2025
    Share Share